Patients who had CT angiography procedures reported lower pain levels, better preparation and were 25 percent more willing to undergo the procedure again in comparison to patients who had invasive coronary angiography, according to newly published research.
Emerging research shows significant patient preference for coronary computed tomography angiography (CCTA) over invasive coronary angiography (ICA).
For the randomized study, recently published in European Radiology, researchers examined findings from 24-hour post-op and long-term follow-up patient questionnaires (median of 3.7 years) for 329 patients who underwent CCTA (167 patients) or ICA (162 patients) for suspected coronary artery disease (CAD).
Thirty-seven percent of the CCTA cohort (62 patients) reported no pain versus 20 percent of the ICA group (33 patients), according to the study. When asked about preparation and information given prior to the procedure, 79 percent of the CCTA group (119 patients) rated it “very good” in comparison to 49 percent of the ICA cohort (69 patients). The researchers noted 73 percent of patients in the CCTA cohort had “very good” satisfaction with the procedure in contrast to 39 percent in the ICA group.
Here one can see examples of coronary CT angiography (CCTA) (left) and invasive coronary angiography (ICA) (right) with both revealing no pathological findings. (Images courtesy of European Radiology.)
The study authors also found that 94 percent of patients in the CCTA group would be willing to undergo the procedure again in comparison to 69 percent of patients who had ICA.
“The principal findings of this randomized trial are as follows: (1) subjective pain was significantly lower in patients who underwent coronary CT angiography compared to those who underwent invasive coronary angiography; patients felt better prepared and less concerned about the CT examination; and there was significantly greater satisfaction with the communication of findings in the CT-first group, which also persisted at follow-up after 3.7 years,” wrote lead study author Maria Bosserdt, Ph.D., who is affiliated with the Department of Radiology at Charite University of Medicine Berlin in Germany, and colleagues.
While acknowledging CT as a non-invasive test that doesn’t usually cause pain, the researchers said the study’s findings on patient preference and satisfaction are key considerations with the ongoing emphasis on valued-based care.
“Patient satisfaction with imaging as well as communication of findings, which persisted over long-term follow-up in our analysis, will also contribute to patient-centered care in radiology,” noted Bosserdt and colleagues. “ … Patient satisfaction constitutes a core component of the shift from volume- to value-based radiology, which also includes better patient satisfaction, outcomes, and overall system savings.”
(Editor’s note: For related content, see “Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?,” “Should Dual-Source CT be the New Standard for ER CCTA Assessment of Acute Chest Pain?” and “Could Photon Counting Reduce Iodinated Contrast Media for CT Angiography?”)
In regard to study limitations, the authors noted it was a single-center study and acknowledged a lack of formal validation for the patient questionnaire. They also conceded that 7 percent of the cohort did not have follow-up data and suggested that clinicians involved with the study may have had greater engagement with those in the CT cohort.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.